Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiling Lu

Showing results (131-140 of 224) with videos related to

Pageof 23
Sort By:
Oncotarget|June 14, 2019
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy optionsMarilyne Labrie, Tae-Beom Kim, Zhenlin Ju, et al.
British Journal of Cancer|March 4, 2021
Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profilingMizunori Yaegashi, Takeshi Iwaya, Noriyuki Sasaki, et al.
Genome Medicine|April 16, 2015
Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancerMiriam Ragle Aure, Sandra Jernström, Marit Krohn, et al.
Molecular & Cellular Proteomics : MCP|March 14, 2018
Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded AntibodiesJinho Lee, Gary K Geiss, Gokhan Demirkan, et al.
Cancer Cell|May 1, 2018
A-to-I RNA Editing Contributes to Proteomic Diversity in CancerXinxin Peng, Xiaoyan Xu, Yumeng Wang, et al.
Science Signaling|January 10, 2013
BSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiationYixin Yao, Milind Suraokar, Bryant G Darnay, et al.
Oncogene|November 10, 2019
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasisChaoyang Sun, Xi Li, Ensong Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA MutationTapsi Kumar, Evie Hobbs, Fei Yang, et al.
Plos One|July 30, 2010
PTK6 regulates IGF-1-induced anchorage-independent survivalHanna Y Irie, Yashaswi Shrestha, Laura M Selfors, et al.
Cancer Research|October 22, 2020
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 SignalingDeepak Parashar, Bindu Nair, Anjali Geethadevi, et al.
Pageof 23

Showing results (131-140 of 224) with videos related to

Sort By:
Pageof 23
Oncotarget|June 14, 2019
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy optionsMarilyne Labrie, Tae-Beom Kim, Zhenlin Ju, et al.
British Journal of Cancer|March 4, 2021
Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profilingMizunori Yaegashi, Takeshi Iwaya, Noriyuki Sasaki, et al.
Genome Medicine|April 16, 2015
Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancerMiriam Ragle Aure, Sandra Jernström, Marit Krohn, et al.
Molecular & Cellular Proteomics : MCP|March 14, 2018
Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded AntibodiesJinho Lee, Gary K Geiss, Gokhan Demirkan, et al.
Cancer Cell|May 1, 2018
A-to-I RNA Editing Contributes to Proteomic Diversity in CancerXinxin Peng, Xiaoyan Xu, Yumeng Wang, et al.
Science Signaling|January 10, 2013
BSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiationYixin Yao, Milind Suraokar, Bryant G Darnay, et al.
Oncogene|November 10, 2019
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasisChaoyang Sun, Xi Li, Ensong Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA MutationTapsi Kumar, Evie Hobbs, Fei Yang, et al.
Plos One|July 30, 2010
PTK6 regulates IGF-1-induced anchorage-independent survivalHanna Y Irie, Yashaswi Shrestha, Laura M Selfors, et al.
Cancer Research|October 22, 2020
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 SignalingDeepak Parashar, Bindu Nair, Anjali Geethadevi, et al.
Pageof 23